Biliary tract carcinoma Hepatocellular carcinoma Metastatic liver carcinoma
Conditions
Interventions
Inchin-ko-to(Tsumura,Japan
7.5g/day)
Control: no treatment
Sponsors
Nagoya University Graduate School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who fulfilled the criteria and agreed with the enrollment in this study.
Exclusion criteria
Exclusion criteria: Patients who reject to be enrolled in this study. Patients who do not fulfill the criteria of this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative liver dysfunction and other complications | — |
Secondary
| Measure | Time frame |
|---|---|
| The Level of inflammatory cytokines and iNOS in the expected remnant liver. | — |
Countries
Japan
Contacts
Public ContactYukihiro Yokoyama
Nagoya University Graduate School of Medicine Department of Surgical Oncology
Outcome results
None listed